ECOR
Price
$7.41
Change
+$0.06 (+0.82%)
Updated
Oct 22 closing price
Capitalization
66.81M
13 days until earnings call
Intraday BUY SELL Signals
QDEL
Price
$13.48
Change
-$0.60 (-4.26%)
Updated
Oct 22 closing price
Capitalization
924.4M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ECOR vs QDEL

ECOR vs QDEL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ECOR vs. QDEL commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECOR is a StrongBuy and QDEL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ECOR with price predictions
Oct 22, 2026

ECOR's RSI Indicator remains in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

ECOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECOR as a result. In 81 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The Moving Average Convergence Divergence Histogram (MACD) for ECOR turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 42 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

ECOR moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ECOR crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ECOR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ECOR's P/B Ratio (-23.945) is slightly lower than the industry average of (2.874). P/E Ratio (-4.491) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.571) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ECOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for QDEL with price predictions
Oct 22, 2026

QDEL in upward trend: 10-day moving average moved above 50-day moving average on October 16, 2026

The 10-day moving average for QDEL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on QDEL as a result. In 56 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for QDEL just turned positive on September 28, 2026. Looking at past instances where QDEL's MACD turned positive, the stock continued to rise in 33 of 49 cases over the following month. The odds of a continued upward trend are 67%.

QDEL moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where QDEL advanced for three days, in 177 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The 10-day RSI Indicator for QDEL moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 18 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QDEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

QDEL broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QDEL entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.521) is normal, around the industry mean (2.874). P/E Ratio (-0.874) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.274) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. QDEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QDEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ECOR vs QDEL: Fundamental Ratings
ECOR
QDEL
OUTLOOK RATING
1..100
5018
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
5845
P/E GROWTH RATING
1..100
6621
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ECOR's Valuation (20) in the Medical Specialties industry is in the same range as QDEL (36). This means that ECOR’s stock grew similarly to QDEL’s over the last 12 months.

ECOR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that ECOR’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's SMR Rating (98) in the Medical Specialties industry is in the same range as ECOR (100). This means that QDEL’s stock grew similarly to ECOR’s over the last 12 months.

QDEL's Price Growth Rating (45) in the Medical Specialties industry is in the same range as ECOR (58). This means that QDEL’s stock grew similarly to ECOR’s over the last 12 months.

QDEL's P/E Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for ECOR (66). This means that QDEL’s stock grew somewhat faster than ECOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ECORQDEL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ECOR: $7.35 vs. QDEL: $14.08)
Brand notoriety: ECOR and QDEL are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ECOR: 56% vs. QDEL: 220%
Market capitalization -- ECOR: $66.81M vs. QDEL: $924.4M
ECOR [@Medical/Nursing Services] is valued at $66.81M. QDEL’s [@Medical/Nursing Services] market capitalization is $924.4M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ECOR’s FA Score shows that 1 FA rating(s) are green while QDEL’s FA Score has 1 green FA rating(s).

  • ECOR’s FA Score: 1 green, 4 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, QDEL is a better buy in the long-term than ECOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ECOR’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 5 bullish TA indicator(s).

  • ECOR’s TA Score: 4 bullish, 6 bearish.
  • QDEL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than ECOR.

Price Growth

ECOR (@Medical/Nursing Services) experienced а -10.37% price change this week, while QDEL (@Medical/Nursing Services) price change was +1.51% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

ECOR is expected to report earnings on Nov 04, 2026.

QDEL is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ECOR
Daily Signal:
Gain/Loss:
QDEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ECOR and

Correlation & Price change

A.I.dvisor tells us that ECOR and SENS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and SENS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
+0.82%
SENS - ECOR
30%
Poorly correlated
-7.15%
QDEL - ECOR
29%
Poorly correlated
-4.26%
PFSA - ECOR
28%
Poorly correlated
+20.11%
AXGN - ECOR
26%
Poorly correlated
+0.55%
BWAY - ECOR
26%
Poorly correlated
-4.51%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with AZTA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-4.26%
AZTA - QDEL
51%
Loosely correlated
-2.04%
XRAY - QDEL
50%
Loosely correlated
+4.63%
RVTY - QDEL
50%
Loosely correlated
+0.48%
DHR - QDEL
49%
Loosely correlated
-1.76%
A - QDEL
48%
Loosely correlated
-2.17%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGOV40.210.13
+0.32%
iShares International Treasury Bond ETF (IGOV)
MEMY14.83N/A
N/A
Tuttle Capital Meme Stock Income Blast ETF (MEMY)
NATO36.22-0.28
-0.77%
Themes Transatlantic Defense ETF (NATO)
WQTM27.35-1.25
-4.37%
WisdomTree Quantum Computing Fund (WQTM)
SLON31.55-3.00
-8.68%
ProShares Ultra Solana ETF (SLON)